SUPERNUS PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q3 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q3 2023.
  • Supernus Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was 2.82 %, a 37.4% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2022 was 7.12 %, a 5.48% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2021 was 6.75 %, a 63.7% decline from 2020.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2020 was 18.6 %, a 11.4% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 2.82 -1.69 -37.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 4.86 -2.12 -30.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 5.96 -3.09 -34.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 7.12 +0.37 +5.48% Oct 1, 2022 Dec 31, 2022
Q3 2022 4.51 -6.05 -57.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 6.98 -6.41 -47.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 9.05 -6.41 -41.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 6.75 -11.8 -63.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 10.6 -9.46 -47.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 13.4 -6.05 -31.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 15.5 -4.85 -23.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 18.6 -2.4 -11.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 20 -1.01 -4.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 19.4 -2.92 -13.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 20.3 -3.29 -13.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 21 -6.47 -23.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 21 -6.57 -23.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 22.4 -5.13 -18.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 23.6 -3.06 -11.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 27.5 +3.45 +14.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 27.6 +1.22 +4.63% Jul 1, 2018 Sep 30, 2018
Q2 2018 27.5 -24.4 -47% Apr 1, 2018 Jun 30, 2018
Q1 2018 26.7 -30.1 -53% Jan 1, 2018 Mar 31, 2018
Q4 2017 24 -39.7 -62.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 26.4 -45.1 -63.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 51.9 +24.2 +87.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 56.8 +35.3 +164% Jan 1, 2017 Mar 31, 2017
Q4 2016 63.7 +45.3 +245% Oct 1, 2016 Dec 31, 2016
Q3 2016 71.5 +54.4 +319% Jul 1, 2016 Sep 30, 2016
Q2 2016 27.7 +19 +220% Apr 1, 2016 Jun 30, 2016
Q1 2016 21.5 +9.17 +74.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 18.5 +49.9 Oct 1, 2015 Dec 31, 2015
Q3 2015 17.1 +130 Jul 1, 2015 Sep 30, 2015
Q2 2015 8.65 +226 Apr 1, 2015 Jun 30, 2015
Q1 2015 12.3 +335 Jan 1, 2015 Mar 31, 2015
Q4 2014 -31.4 +268 +89.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -113 +114 +50.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -217 -34.7 -19% Apr 1, 2014 Jun 30, 2014
Q1 2014 -323 -185 -135% Jan 1, 2014 Mar 31, 2014
Q4 2013 -300 -253 -538% Oct 1, 2013 Dec 31, 2013
Q3 2013 -227 -283 -498% Jul 1, 2013 Sep 30, 2013
Q2 2013 -183 Apr 1, 2013 Jun 30, 2013
Q1 2013 -137 Jan 1, 2013 Mar 31, 2013
Q4 2012 -47 Oct 1, 2012 Dec 31, 2012
Q3 2012 56.9 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.